Suppr超能文献

[MIC2(CD99)作为TdT阴性B淋巴细胞淋巴瘤的诊断标志物]

[MIC2 (CD99) as a diagnostic marker for TdT-negative B lymphoblastic lymphoma].

作者信息

Ikeda Naoto, Imao Takeshi, Hisano Yuki, Kamao Takayuki, Uno Masatoshi, Mizushima Takaaki

机构信息

Department of Internal Medicine, Kaneda Hospital.

出版信息

Rinsho Ketsueki. 2023;64(2):130-132. doi: 10.11406/rinketsu.64.130.

Abstract

Lymphoblastic lymphoma (LBL) is a rare hematologic malignancy that originates from immature lymphocytes and usually expresses terminal deoxynucleotidyl transferase (TdT). Here, we report a case of TdT-negative B-LBL. A 71-year-old male patient presented to a hospital with shortness of breath. His chest computed tomography showed a mediastinal mass. Tumor cells did not express TdT but expressed MIC2, which led to LBL diagnosis. MIC2 is a useful marker for LBL diagnosis.

摘要

淋巴母细胞淋巴瘤(LBL)是一种罕见的血液系统恶性肿瘤,起源于未成熟淋巴细胞,通常表达末端脱氧核苷酸转移酶(TdT)。在此,我们报告一例TdT阴性的B-LBL病例。一名71岁男性患者因呼吸急促入院。他的胸部计算机断层扫描显示纵隔肿块。肿瘤细胞不表达TdT,但表达MIC2,从而确诊为LBL。MIC2是LBL诊断的有用标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验